Finance

Lists
Q910:FRA
Annexin Pharmaceuticals AB (publ)
€ ०.७७
-०.२६%
(-०.००२०) 1D
अक्टोबर ९, २२:००:०० GMT+२  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for Q910...
Open
€ ०.७७
High
€ ०.७७
Low
€ ०.७७
Mkt. cap
७.९२ करोड
Avg. vol.
७०.००
Volume
०.००
52-wk high
€ २.५८
52-wk low
€ ०.७६
No. of employees
४
Open
€ ०.७७
High
€ ०.७७
Low
€ ०.७७
Mkt. cap
७.९२ करोड
Avg. vol.
७०.००
Volume
०.००
52-wk high
€ २.५८
52-wk low
€ ०.७६
No. of employees
४
News stories
From web sources and news partners
About Annexin Pharmaceuticals AB (publ)
CEO-
Employees४
Founded२०१४
Headquarters-
Sector-
Websiteannexinpharma.se
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
७०.५३ लाख
८०.०१ लाख
७९.२२ लाख
८४.७६ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२३.४८ लाख
२२.५७ लाख
२८.९६ लाख
२९.५५ लाख
Operating expense
९४.०१ लाख
१.०३ करोड
१.०८ करोड
१.११ करोड
Total operating expenses
९४.०१ लाख
१.०३ करोड
१.०८ करोड
१.११ करोड
Operating income
-९४.०१ लाख
-१.०३ करोड
-१.०८ करोड
-१.११ करोड
Other non operating income
-
-
-
१.०० हजार
EBT including unusual items
-९९.०१ लाख
-१.०५ करोड
-१.०५ करोड
-१.१६ करोड
EBT excluding unusual items
-९९.०१ लाख
-१.०५ करोड
-१.०५ करोड
-१.१६ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-२.८८ लाख
Net income
-९९.०१ लाख
-१.०५ करोड
-१.०५ करोड
-१.१६ करोड
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
१.५४ लाख
२.३१ लाख
३४.०० हजार
-
Interest expense
-
-
-
-
Net interest expenses
१.५४ लाख
२.३१ लाख
३४.०० हजार
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-९३.५३ लाख
-१.०२ करोड
-१.०८ करोड
-१.११ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू